The 5K@ADA virtual 5K run/walk event is coming soon! Registration is open!
Registration is free.
The 5K@ADA Virtual Challenge will bring together people across the globe as well as ADA attendees to emphasize the need for increased physical activity to help prevent diabetes and diabetes complications. This disease awareness activity provides participants with the opportunity to raise public awareness about the importance of a healthy lifestyle in preventing and controlling diabetes.
The 5K@ADA is sponsored by Novo Nordisk and the American Diabetes Association (ADA). It takes place in conjunction with the ADA annual conference.
I do the walk on the treadmill at the gym. This way I can have my earbuds in, easily track my progress and not have any interruptions.
Upload your race time any time between the race start and end dates.
5K@ADA Virtual Challenge
https://www.ada5k.com/
June 18 - June 22, 2025
Registration is open. Personalized bibs are available 48 hours after signup.
Continue driving change in diabetes by running or walking the 5K@ADA in Chicago or from your home city!
Novo Nordisk has expanded its collaboration with Valo Health, committing $190 million in near-term payments and up to $4.6 billion in potential milestone payments to accelerate the discovery and development of treatments for obesity, type 2 diabetes, and cardiovascular diseases. The expanded agreement, building on their 2023 partnership, increases the number of programs from 11 to 20, increasing their focus on cardiometabolic innovation.
Novo Nordisk leaders have expressed their enthusiasm for the partnership in LinkedIn posts. Marcus Schindler, Novo Nordisk’s Executive Vice President and Chief Scientific Officer, highlighted the strong scientific synergies and high engagement between the teams, emphasizing how leveraging human datasets early in the R&D process is driving scientific excellence. Similarly, Dave Moore, Executive Vice President of US Operations, celebrated the rapid expansion as a testament to the value created by combining Novo Nordisk’s deep understanding of cardiometabolic diseases with Valo’s AI-powered platform.
At the core of the partnership is Valo’s Opal Computational Platform™, a groundbreaking AI-powered system designed to accelerate drug discovery and development by leveraging high-quality human data. Unlike traditional approaches, which are often hindered by fragmented data and inefficiencies, Opal integrates large-scale human-centric datasets with advanced machine learning models. The platform continuously learns and improves by generating and integrating new data during every stage of drug development. It also incorporates proprietary Biowire technology to produce human-relevant tissue in the lab, enabling precise simulations of drug responses before clinical trials. This end-to-end approach minimizes data loss, accelerates insights, and aims to produce more effective treatments that reach patients faster.
This initiative underscores Novo Nordisk's strategic investment in AI and reinforces its commitment to combating chronic diseases. As the two companies expand their partnership, the focus remains on achieving groundbreaking advancements in cardiometabolic treatments.
For more information, please visit Fierce Biotech.
Left to right: Jensen Huang, founder and CEO of NVIDIA | Nadia Carlsten, CEO of DCAI | HM King Frederik X of Denmark
Source: Novo Nordisk Foundation
Denmark has ushered in a new era of artificial intelligence with the launch of its first AI supercomputer, Gefion. This groundbreaking system, developed on the NVIDIA DGX SuperPOD platform, was ceremonially powered on by NVIDIA’s CEO Jensen Huang and King Frederik X of Denmark, marking a pivotal moment in the nation’s technological advancement.
Gefion, which is operated by the Danish Centre for AI Innovation (DCAI), is designed to solve some of the most complex challenges across sectors like biotechnology, quantum computing, and clean energy. Thomas Senderovitz, Senior VP Data Science at Novo Nordisk, wrote in a public LinkedIn post about the event, “Today, the amazing and groundbreaking Gefion supercomputer—the new Danish world-class instrument for generating insights and solving complex problems through artificial intelligence—was turned on by NVIDIA’s CEO and founder Jensen Huang and HM King Frederik. A very special moment to remember for generations to come!”
The supercomputer is part of a larger public-private initiative, funded by the Novo Nordisk Foundation and the Export and Investment Fund of Denmark, and it stands as Denmark’s largest sovereign AI infrastructure. This positions Denmark not only as a leader in AI research and innovation but also enhances the country’s ability to address global challenges, from accelerating drug discovery to improving climate models.
With the Gefion supercomputer, Denmark aims to foster an AI ecosystem that reflects its unique cultural and industrial strengths, while advancing the scientific community's ability to tackle some of the world’s most pressing issues.
For more information about Gefion and DCAI, visit the Danish Centre for AI Innovation.
The 5K@EASD virtual 5K run/walk event is coming soon! Registration opens Monday July 15.
Registration is free.
The 5K@EASD Virtual Challenge will bring together people across the globe as well as EASD attendees to emphasize the need for increased physical activity to help prevent diabetes and diabetes complications. This disease awareness activity provides participants with the opportunity to raise public awareness about the importance of a healthy lifestyle in preventing and controlling diabetes.
The 5K@EASD is sponsored by Novo Nordisk and the World Diabetes Foundation. It takes place in conjunction with the European Association for the Study of Diabetes (EASD) annual conference.
I do the walk on the treadmill at the gym. This way I can have my earbuds in, easily track my progress and not have any interruptions.
Upload your race time any time between the race start and end dates.
5K@EASD Virtual Challenge
https://www.easd5k.com/
September 7 through September 11, 2024
Registration opens July 15. Personalized bibs will be available August 7. Finisher certificates will be available September 8.
Continue driving change in diabetes by running or walking the 5K@EASD in Madrid or from your home city!
#EASD2024 #5KEASD #DiabetesAwareness #DrivingChange
Page 1 of 2
